Disease-related costs and utilities used in the model
| Disease state | Type of care; cost, $ | Utility decrement (range) | References | |
|---|---|---|---|---|
| Hospital | Community (annual) | |||
| Portal hypertension | 17 280 | 2776 | 0.018 (0.015–0.022) | Sullivan et al., (41) Alberta Health Care Insurance Plan, (42) Alberta drug benefit list, (43) Runyon (44) |
| CNS involvement | 38 009 | 0 | 0 | Alberta Health Care Insurance Plan, (42) Betting et al. (45) |
| Cor pulmonale | 12 639 | 1627 | 0.055 (0.052–0.058) | Sullivan et al., (41) Alberta Health Care Insurance Plan, (42) Howlett et al. (46) |
| Glomerulonephritis | 14 065 | 163 | 0.054 (0.051–0.058) | Sullivan et al., (41) Alberta Health Care Insurance Plan, (42) KDIGO Glomerulonephritis Working Group (47) |
| Variceal hemorrhage | 7821 | 909 | 0 | Alberta Health Care Insurance Plan, (42) Garcia-Tsao et al. (48) |
| Intestinal malabsorption | 7386 | 0 | 0 | Alberta Health Care Insurance Plan (42) |
| Pulmonary hypertension | 23 637 | 245 | 0.043 (0.042–0.043) | Alberta Health Care Insurance Plan, (42) Sullivan and Ghushchyan, (49) Provencher and Granton (50) |
| Bladder cancer | 12 366 | 23 612 | 0.017 (0.017–0.018) | Alberta Health Care Insurance Plan, (42) Sullivan and Ghushchyan, (49) Kassouf et al. (51) |
| Genital infection | 4855 | 0 | 0 | Alberta Health Care Insurance Plan (42) |
| Infertility | 0 | 16 181 | 0.070 (0.067–0.073) | Collins et al., (52) Scotland et al. (53) |
| Pyelonephritis | 6070 | 0 | 0 | Alberta Health Care Insurance Plan (42) |
| Bacteremia | 62 478 | 0 | 0 | Alberta Health Care Insurance Plan (42) |
| Hydronephrosis | 5441 | 0 | 0 | Alberta Health Care Insurance Plan (42) |
| Two comorbidities | – | – | 0.091 (0.090–0.092) | Sullivan and Ghushchyan (49) |
| Three comorbidities | – | – | 0.084 (0.082–0.086) | Sullivan and Ghushchyan (49) |
| Baseline health state | – | – | 0.120 | Sullivan et al. (41) |
Note: CNS = central nervous system.